Prelude Therapeutics (PRLD)
NASDAQ: PRLD
· Real-Time Price · USD
1.47
0.03 (2.08%)
At close: Oct 03, 2025, 3:59 PM
1.47
0.00%
After-hours: Oct 03, 2025, 04:10 PM EDT
13F Institute Ownership
Total Institutes of 45 in Prelude Therapeutics reduced their positions with a decrease of 12 investors compared to the previous quarter. A reduction of 1.69M shares, as total invested capital declined by $3.68M with ownership percentage dropping from 37.34% to 35.11%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Orbimed Advisors LLC | 14.36% | 10.91M | +0.00% | 8.83M | 0.22% | Aug 14, 2025 |
| Baker Bros. Advisors LP | 13.32% | 10.12M | +0.00% | 8.19M | 0.08% | Aug 14, 2025 |
| Vanguard Group Inc | 1.23% | 932.57K | -7.59% | 754.45K | < 0.01% | Aug 11, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.